The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings-Reference-Cited by-同舟云学术

The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings

Published:2019-05 Issue: Volume:30 Page:187-191
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Kolcava Jan,Hulova Monika,Benesova Yvonne,Bednarik Josef,Stourac Pavel

Funder

Ministry of Health

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference27 articles.

1. . Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain;Aladro;J. Neurol. Sci.,2016

2. . Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N. Engl. J. Med.,2012

3. JC virus antibody status underestimates infection rates;Berger;Ann. Neurol.,2013

4. Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1;Bozic;Ann. Neurol..,2011

5. . BK virus antibody titers and intensity of infections after renal transplantation;Bohl;J. Clin. Virol.,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations;Multiple Sclerosis and Related Disorders;2023-09

2. Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-12

3. Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders;Fluids and Barriers of the CNS;2022-07-29

4. Multiple Sclerosis;Annals of Internal Medicine;2021-06

5. JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies;Journal of Clinical Medicine;2021-05-06